{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:47:00Z","timestamp":1791568020664,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.drugalcdep.2020.108244","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T21:05:54Z","timestamp":1598043954000},"page":"108244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder"],"prefix":"10.1016","volume":"216","author":[{"given":"Erik Loewen","family":"Friesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kurdyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108244_bib0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.drugalcdep.2013.03.015","article-title":"How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities","volume":"132","author":"Arndt","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"25","key":"10.1016\/j.drugalcdep.2020.108244_bib0010","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat. Med."},{"key":"10.1016\/j.drugalcdep.2020.108244_bib0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drugalcdep.2019.03.014","article-title":"Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths","volume":"200","author":"Barocas","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108244_bib0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.addbeh.2010.12.001","article-title":"Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders","volume":"36","author":"Brown","year":"2011","journal-title":"Addict. Behav."},{"issue":"22","key":"10.1016\/j.drugalcdep.2020.108244_bib0025","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M","article-title":"A simple method for converting an odds ratio to effect size for use in meta-analysis","volume":"19","author":"Chinn","year":"2000","journal-title":"Stat. Med."},{"key":"10.1016\/j.drugalcdep.2020.108244_bib0030","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"2013"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108244_bib0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harv. Rev. Psychiatry"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108244_bib0040","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/sw\/43.5.470","article-title":"Improving compliance with the initial outpatient session among discharged inpatient dual diagnosis clients","volume":"43","author":"Daley","year":"1998","journal-title":"Soc Work"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108244_bib0045","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/add.12551","article-title":"The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108244_bib0050","series-title":"Mental Health Policy Implementation Guide: Dual Diagnosis Good Practice Guide..","author":"Department of Health","year":"2002"},{"issue":"1\u20132","key":"10.1016\/j.drugalcdep.2020.108244_bib0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2012.12.010","article-title":"Patient characteristics associated with buprenorphine\/naloxone treatment outcome for prescription opioid dependence: results from a multisite study","volume":"131","author":"Dreifuss","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108244_bib0060","first-page":"126","article-title":"Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic","volume":"43","author":"Gelkopf","year":"2006","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108244_bib0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","article-title":"Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome","volume":"75","author":"Gerra","year":"2004","journal-title":"Drug Alcohol Depend."},{"issue":"16","key":"10.1016\/j.drugalcdep.2020.108244_bib0070","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/jama.2017.13358","article-title":"Reframing the opioid epidemic as a national emergency","volume":"318","author":"Gostin","year":"2017","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108244_bib0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108244_bib0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.drugalcdep.2018.12.030","article-title":"Co-occurring substance use and mental disorders among adults with opioid use disorder","volume":"197","author":"Jones","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108244_bib0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drugalcdep.2017.02.006","article-title":"The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. National sample","volume":"175","author":"Krawczyk","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108244_bib0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/09503151003686684","article-title":"Dual diagnosis (drug\/alcohol and mental health): service user experiences","volume":"22","author":"Lawrence-Jones","year":"2010","journal-title":"Practice: Social Work in Action"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108244_bib0095","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/07418825.2013.797485","article-title":"Kicked out or dropped out? Disaggregating the effects of community-based treatment attrition on juvenile recidivism","volume":"32","author":"Lockwood","year":"2015","journal-title":"Justice Q."},{"issue":"3 Suppl","key":"10.1016\/j.drugalcdep.2020.108244_bib0100","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108244_bib0105","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/ajad.12414","article-title":"Predictors of early dropout in outpatient buprenorphine\/naloxone treatment","volume":"25","author":"Marcovitz","year":"2016","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2020.108244_bib0110","first-page":"67","article-title":"Affordable housing, homelessness, and mental health: what heath care policy needs to address","author":"Martin","year":"2015","journal-title":"J. Health Hum. Serv. Adm."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108244_bib0115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10488-012-0449-1","article-title":"Dual diagnosis capability in mental health and addiction treatment services: an assessment of programs across multiple state systems","volume":"41","author":"McGovern","year":"2014","journal-title":"Adm. Policy Ment. Health"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108244_bib0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1521-0391.2013.00317.x","article-title":"Predictors of dropout from psychosocial treatment in opioid-dependent outpatients","volume":"22","author":"McHugh","year":"2013","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2020.108244_bib0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jsat.2015.12.007","article-title":"Racial and ethnic disparities in outpatient substance use disorder treatment episode completion for different substances","volume":"63","author":"Mennis","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2020.108244_bib0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.drugalcdep.2015.07.004","article-title":"Factors associated with substance use treatment completion in residential facilities","volume":"154","author":"Mutter","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108244_bib0135","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011117.pub2","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","author":"Nielsen","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108244_bib0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0895-4356(00)00321-8","article-title":"Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores","volume":"54","author":"Normand","year":"2001","journal-title":"J. Clin. Epidemiol."},{"issue":"10","key":"10.1016\/j.drugalcdep.2020.108244_bib0145","first-page":"1305","article-title":"Pre- and post-admission attrition of homeless, mentally ill chemical abusers referred to residential treatment programs","volume":"92","author":"Nuttbrock","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108244_bib0150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2019.05.026","article-title":"Stress, craving and mood as predictors of early dropout from opioid agonist therapy","volume":"202","author":"Panlilio","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108244_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107952","article-title":"Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: associations moderated by state Medicaid expansion status, race\/ethnicity and gender, and year","volume":"209","author":"Pro","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108244_bib0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/ADM.0000000000000456","article-title":"Medication treatment with methadone or buprenorphine: differential reasons for premature discharge","volume":"13","author":"Proctor","year":"2019","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2020.108244_bib0165","article-title":"SAS\/STAT. Cary, NC","author":"SAS Institute Inc","year":"2020","journal-title":"USA."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108244_bib0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000274177","article-title":"Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment","volume":"43","author":"Schafer","year":"2010","journal-title":"Psychopathology"},{"key":"10.1016\/j.drugalcdep.2020.108244_bib0175","unstructured":"Substance Abuse and Mental Health Services Administration, 2015-17. Treatment Episode Data Set (TEDS)."},{"issue":"7","key":"10.1016\/j.drugalcdep.2020.108244_bib0180","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00127-004-0790-0","article-title":"Social exclusion in clients with comorbid mental health and substance misuse problems","volume":"39","author":"Todd","year":"2004","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"8\u20139","key":"10.1016\/j.drugalcdep.2020.108244_bib0185","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3109\/10826084.2012.663296","article-title":"Psychiatric co-morbidity and substance use disorders: treatment in parallel systems or in one integrated system?","volume":"47","author":"Torrens","year":"2012","journal-title":"Subst. Use Misuse"},{"issue":"10118","key":"10.1016\/j.drugalcdep.2020.108244_bib0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(17)32893-3","article-title":"Medications for opioid use disorder: bridging the gap in care","volume":"391","author":"Volkow","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108244_bib0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tics.2011.11.002","article-title":"Stigma as a barrier to recovery from mental illness","volume":"16","author":"Wahl","year":"2012","journal-title":"Trends Cogn. Sci. (Regul. Ed.)"},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108244_bib0200","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.addbeh.2012.04.011","article-title":"Predictors of attrition with buprenorphine\/naloxone treatment in opioid dependent youth","volume":"37","author":"Warden","year":"2012","journal-title":"Addict. Behav."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108244_bib0205","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1213\/ANE.0000000000002496","article-title":"Risk factors for opioid-use disorder and overdose","volume":"125","author":"Webster","year":"2017","journal-title":"Anesth. Analg."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:06:57Z","timestamp":1759828017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620304099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":41,"alternative-id":["S0376871620304099"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108244","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108244"}}